InvestorsHub Logo
Followers 20
Posts 2405
Boards Moderated 0
Alias Born 01/27/2022

Re: Whalatane post# 423588

Saturday, 04/27/2024 4:16:13 PM

Saturday, April 27, 2024 4:16:13 PM

Post# of 424213
Kiwi, I don't disagree that the Big 3 Euro countries are a problem. However, I don't see Amarin choosing to do any trials that would be "necessary" to approve V in these countries. It would take too long and be too costly. Not to mention, there is always the risk that something goes wrong with the trial.

I believe they will eventually succeed in Italy and France. But it will just take more time, and more data coordination (ie. RWE data, as well as additional R-It cohort analysis). I have no idea what will come of Germany. But in any event, I don't think additional trials will be the answer. So, I'm not sure where all this extra cash will be needed.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News